Penumbra (PEN) Other Operating Expenses (2018 - 2024)

Penumbra's (PEN) quarterly Other Operating Expenses came in at $76.9 million in Q2 2024, up 322.43% on a QoQ basis from $18.2 million in Q3 2023.

Penumbra (PEN) Other Operating Expenses (2018 - 2024) Analysis & Trends

Penumbra (PEN) has 3 years of Other Operating Expenses data on file, last reported at $76.9 million in Q2 2024.

On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $76.9 million in Q2 2024; TTM through Mar 2025 was $76.9 million, a 322.43% increase from a year earlier, with the FY2024 full-year figure at $76.9 million, up 322.43% from the prior year.
Other Operating Expenses for Q2 2024 stood at $76.9 million, up from $18.2 million in the prior quarter.
Over the last five years, Other Operating Expenses for PEN reached as high as $76.9 million in Q2 2024 and fell as low as $18.2 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Penumbra	12.48 Bn	11.87 Bn	253.41 Mn

Download Data